Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Lung Cancer

Free Subscription 27.07.2026 1 Am J Clin Oncol 2 Am J Respir Crit Care Med 1 Am J Surg 1 Ann Surg Oncol 4 Ann Thorac Surg 1 BMC Cancer 1 Br J Cancer 1 Cancer 1 Cancer Epidemiol Biomarkers Prev 5 Cancer Lett 1 Cancer Res 1 Cancer Sci 1 Clin Cancer Res 4 Clin Lung Cancer 1 Eur J Cancer 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 1 J Cancer Res Clin Oncol 1 J Clin Oncol 1 J Natl Cancer Inst 5 Lung Cancer 2 Oncogene 1 Oncol Rep 1 Oncologist 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Oncol

1. LI P, Xiong Y
   Development and Validation of Palmitoylation-Related Genes in the Prognostic and Immunologic Characterization of Lung Adenocarcinoma.
   Am J Clin Oncol. 2026;49:361-371.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

2. ZHOU J, Xie X, Zhou C
   Hypoxic Niche as an Early Determinant of EGFR-Mutant Lung Cancer Progression: Implications for Detection, Intervention, and Subtype-Specific Responses.
   Am J Respir Crit Care Med. 2026 Jul 23:aamag379. doi: 10.1093.
   PubMed        
   
   
3. MENG F, Xia Z, Wang S, Wang Q, et al
   Reply to Zhou et al.: Hypoxic Niche as an Early Determinant of EGFR-Mutant Lung Cancer Progression: Implications for Detection, Intervention, and Subtype-Specific Responses.
   Am J Respir Crit Care Med. 2026 Jul 23:aamag380. doi: 10.1093.
   PubMed        
   
   

   
   Am J Surg

4. VIANA SW, Kelty CE, Nasir MU, Haugen CE, et al
   National analysis of factors associated with patient-clinician discussions about lung cancer screening.
   Am J Surg. 2026;260:117131.
   PubMed        
   
   

   
   Ann Surg Oncol

5. NAEEM W, Broad S, Denson KL, Seder CW, et al
   ASO Author Reflections: Is Histology More Than a Covariate? Revisiting Squamous Cell Carcinoma and Adenocarcinoma in Resected Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2026 Jul 23. doi: 10.1245/s10434-026-20245.
   PubMed        
   
   

   
   Ann Thorac Surg

6. GOCHI AM, Wang T, Kwak HV, Huang Perez AK, et al
   Risk of Primary Lung Cancer in Women with Personal History of Breast Cancer and Subsequent Treatment Modality in an Integrated Health System.
   Ann Thorac Surg. 2026 Jul 24:S0003-4975(26)00731.
   PubMed         Abstract available
   
   
7. KAMTAM DN, Bonnell LN, Kapula N, Engelhardt KE, et al
   A Society of Thoracic Surgeons General Thoracic Surgery Database Analysis of the Association Between Lymph Node Dissection and Chylothorax.
   Ann Thorac Surg. 2026;122:291-300.
   PubMed         Abstract available
   
   
8. XU Y, Wang Z, Pan H, Tan Q, et al
   Is Sublobar Resection Optimal for Peripheral Nodules
   Ann Thorac Surg. 2026;122:302-309.
   PubMed         Abstract available
   
   
9. NASRALLA A, Cypel M
   A Novel Approach for Resection of Centrally Located Metastatic Sarcoma to the Lung.
   Ann Thorac Surg. 2026;122:493-494.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. GULBAGCI B, Kucukarda A, Fenercioglu OE, Nazaroglu A, et al
    Beyond tumor burden: PET/CT-derived psoas muscle quality and survival outcomes in metastatic NSCLC patients treated with nivolumab.
    BMC Cancer. 2026;26:879.
    PubMed         Abstract available
    
    

    
    Br J Cancer

11. ALHATTAB RAN, McKinley JM, Hunter RF, Delargy CM, et al
    Reply to 'Clarifying causal and translational inference in studies of ambient PM(2.5) and lung cancer'.
    Br J Cancer. 2026 Jul 20. doi: 10.1038/s41416-026-03554.
    PubMed        
    
    

    
    Cancer

12. HEINZ AT, Heesen P, Merks JHM, Minard-Colin V, et al
    The impact of whole lung irradiation in lung metastatic rhabdomyosarcoma: A pooled analysis of two European trials and one European registry.
    Cancer. 2026;132:e70530.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

13. LE DH, Cai H, Yu D, Nguyen SM, et al
    Associations between metabolomic signatures of persistent smoking effects and lung cancer risk among former smokers.
    Cancer Epidemiol Biomarkers Prev. 2026.
    PubMed         Abstract available
    
    

    
    Cancer Lett

14. DONG Q, Dong M, Liu X, Zhou J, et al
    Salivary adenoid cystic carcinoma-derived alpha2,6-sialylated extracellular vesicles increase vascular permeability by triggering ER-stress in endothelial cells and promote lung metastasis.
    Cancer Lett. 2025;611:217407.
    PubMed         Abstract available
    
    
15. TERADA T, Suzuki T, Ohnuki K, Yoshikawa T, et al
    T-cell receptor-engineered T-cell therapy using a glypican-3-specific TCR derived from a hepatoblastoma vaccine responder for HLA-A2-positive glypican-3-expressing cancers.
    Cancer Lett. 2026;657:218695.
    PubMed         Abstract available
    
    
16. LUO B, Zhan Q, Chen Y, Zhou Q, et al
    A novel immune checkpoint-based signature predicts immunotherapy benefit in "driver gene-negative" lung adenocarcinoma.
    Cancer Lett. 2026;657:218726.
    PubMed         Abstract available
    
    
17. CHEN S, Weng L, Liu X, Sun Z, et al
    Circular RNA-based therapeutic vaccine elicits potent antigen-specific antitumor immunity and remodels tumor microenvironment in lung cancer.
    Cancer Lett. 2026;658:218743.
    PubMed         Abstract available
    
    
18. NWADOZI E, Strell C, Nordling S, Lindberg A, et al
    Vascular leakage in non-small cell lung cancer is associated with immune evasion and poor response to immunotherapy.
    Cancer Lett. 2026 Jul 22:218728. doi: 10.1016/j.canlet.2026.218728.
    PubMed         Abstract available
    
    

    
    Cancer Res

19. LEI YN, Qin D, He Y, Shu P, et al
    Parallel 4-1BB Signaling in Dual DLL3/CD56-Targeting CAR-T Cells Triggers Adaptive Proliferation and Functional Persistence to Eradicate Small Cell Lung Cancer.
    Cancer Res. 2026 Jul 23. doi: 10.1158/0008-5472.CAN-25-5261.
    PubMed         Abstract available
    
    

    
    Cancer Sci

20. WEI C, Liu X, Hu S, Shen X, et al
    MEN1 Deficiency Drives Lung Cancer Progression via Activation of MMP10-Mediated Angiogenesis.
    Cancer Sci. 2026 Jul 21:10.1111/cas.70470. doi: 10.1111/cas.70470.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

21. NIKNAFS N, Sivapalan L, Balan A, Wehr J, et al
    Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity study.
    Clin Cancer Res. 2026 Jul 23. doi: 10.1158/1078-0432.CCR-26-0656.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

22. SINGHI EK, Sanchez N, Vokes N, Gibbons DL, et al
    Accelerating Lung Cancer Management Through Previsit Liquid Biopsy: Results From the LUNG-FAST Pilot Study.
    Clin Lung Cancer. 2026;27:13-17.
    PubMed         Abstract available
    
    
23. GEMINE RE, Davies GR, Lewis KE
    Quitting Smoking and Two-Year Survival After a Diagnosis of Small-Cell Lung Cancer.
    Clin Lung Cancer. 2026;27:18-23.
    PubMed         Abstract available
    
    
24. LIU Y, Li D, Wu L, Li X, et al
    Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant Non-Small Cell Lung Cancer: Final Analysis of the Phase 2, Single-Arm DESTINY-Lung05 Trial.
    Clin Lung Cancer. 2026;27:24-32.
    PubMed         Abstract available
    
    
25. SMILNAK G, Singh R, Dougherty SC, Maheshwari S, et al
    Next-Generation Sequencing Completion and Timeliness Using a Reflex Testing Protocol for Patients with Stage II to IV Nonsquamous Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2026;27:33-41.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

26. NGUYEN D, Lee SH, Lu S, Girard N, et al
    Assessing time to symptomatic progression, a patient-relevant efficacy endpoint, in the MARIPOSA study in non-small cell lung cancer.
    Eur J Cancer. 2026;245:116938.
    PubMed         Abstract available
    
    

    
    Int J Cancer

27. MEGYESFALVI Z, Paz-Ares L, Dome B
    High Endothelial Venules as Conduits for Antitumor Immune Cell Trafficking in Small Cell Lung Cancer.
    Int J Cancer. 2026 Jul 21. doi: 10.1002/ijc.70659.
    PubMed        
    
    

    
    Int J Radiat Oncol Biol Phys

28. WIJESOORIYA K, Nguyen C, Conaway MR, Read PW, et al
    First Measurement: Proactively Sparing the Immune System During SBRT to Early-Stage Lung Cancer-A Randomized Phase II Study.
    Int J Radiat Oncol Biol Phys. 2026 Jul 22:S0360-3016(26)04026.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

29. WEN SWC, Timm S, Borg M, Hilberg O, et al
    The prognostic potential of an immunology score in patients treated with curative surgery for non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2026 Jul 21. doi: 10.1007/s00432-026-06562.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

30. ZHAO Y, Zhao H, Wang Q, Yang K, et al
    Izalontamab Brengitecan (Iza-Bren), a First-in-Class EGFR-HER3 Bispecific Antibody-Drug Conjugate in Extensive-Stage Small Cell Lung Cancer: Results From a Phase Ib Study.
    J Clin Oncol. 2026 Jul 24:JCO2600243. doi: 10.1200/JCO-26-00243.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

31. MASTRANTONI L, Vitale A, Russo J, Giordano G, et al
    Design-Outcome Concordance in Targeted-Therapy trials in Non-Small cell lung cancer: a Meta-Research study.
    J Natl Cancer Inst. 2026 Jul 20:djag241. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lung Cancer

32. DE MARINIS F, Cascone T, Forde PM, Passaro A, et al
    Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert panel meeting by AIOT.
    Lung Cancer. 2026;219:109533.
    PubMed         Abstract available
    
    
33. SCATTOLIN D, Heijboer FWJ, Pigato G, Derks JL, et al
    Analysis of SLFN11 expression in small cell lung cancer, carcinoids and large cell neuroendocrine carcinoma: insights into lung neuroendocrine neoplasms.
    Lung Cancer. 2026;219:109539.
    PubMed         Abstract available
    
    
34. LE QV, Nguyen KK, Ngo LL, Bui TT, et al
    Community-based low-dose computed tomography lung cancer screening program in Vietnam: evidence for national policy.
    Lung Cancer. 2026;219:109541.
    PubMed         Abstract available
    
    
35. HO C, D'amours MF, Bhang E, Chan A, et al
    CT surveillance, patterns of recurrence and eligibility for salvage therapy after curative intent treatment for unresectable stage III non small cell lung cancer.
    Lung Cancer. 2026;219:109535.
    PubMed         Abstract available
    
    
36. ROUSSEAU A, Foix-Colonier A, Luu J, Foulon S, et al
    Impact of immunotherapy on overall survival and healthcare costs in advanced/metastatic lung cancer: A real-world study in France.
    Lung Cancer. 2026;219:109549.
    PubMed         Abstract available
    
    

    
    Oncogene

37. LIANG Y, Guo Y, Huang X, Wang Q, et al
    The splicing factor hnRNPA1 promotes osimertinib resistance in lung adenocarcinoma by regulating NEDD4L alternative splicing.
    Oncogene. 2026;45:3039-3052.
    PubMed         Abstract available
    
    
38. ZHANG L, Weng G, Liu C, Li R, et al
    Activation of the NF-kappaB/ALDH1A1 signaling promotes non-mutational resistance to EGFR-TKIs in non-small cell lung cancer.
    Oncogene. 2026 Jul 23. doi: 10.1038/s41388-026-03907.
    PubMed         Abstract available
    
    

    
    Oncol Rep

39. ZHANG Q, Sun Y, Zhuang Y, Xu S, et al
    M2?TAM?derived exosomal miR?491?3p modulates UBE2D3 and promotes the proliferation, migration and invasion of lung cancer cells.
    Oncol Rep. 2026;56:159.
    PubMed         Abstract available
    
    

    
    Oncologist

40. TOMECHKO K, Azenkot T, Conway DA, Patel SP, et al
    Fertility treatment using assisted reproductive technology during immune checkpoint inhibition: report of two cases.
    Oncologist. 2026;31:oyag273.
    PubMed         Abstract available
    
    

    
    PLoS One

41. LEI L, Jiang Y, Feng G, Li J, et al
    The current status of health literacy among caregivers of lung cancer patients:A cross-sectional survey.
    PLoS One. 2026;21:e0345901.
    PubMed         Abstract available
    
    
42. FREIHAT O, Aamir M, Cselik Z, Kovacs A, et al
    Global lung cancer burden, trends, and projections from 2010 to 2050: A population-level severity framework integrating DALYs-per-case and mortality-to-incidence ratio.
    PLoS One. 2026;21:e0354350.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum